Qiagen Fully Acquires NeuMoDx Molecular
The acquisition rounds out Qiagen’s portfolio of automated molecular testing solutions based on the proven PCR technology.
Read MorePosted by Melanie Hamilton-Basich | Sep 18, 2020 | Company News, Molecular Diagnostics |
The acquisition rounds out Qiagen’s portfolio of automated molecular testing solutions based on the proven PCR technology.
Read MorePosted by Laurie Bonner | Sep 18, 2020 | Covid 19, Miscellaneous |
The work could lead to tools like smartphone apps and wearable devices that can identify and trace contacts and track verified covid-19 test results.
Read MorePosted by Laurie Bonner | Sep 18, 2020 | Covid 19 |
A controversial guideline saying people without covid-19 symptoms didn’t need to get tested for the virus came from HHS officials and skipped the CDC’s scientific review process, according to The New York Times.
Read MorePosted by Melanie Hamilton-Basich | Sep 18, 2020 | Covid 19 |
Two FDA directors share the lessons learned during the evolution of the emergency use of diagnostics for SARS-CoV-2 during the covid-19 pandemic.
Read MorePosted by Melanie Hamilton-Basich | Sep 17, 2020 | Company News, Covid 19 |
The thresholds displayed in the standardized unit of measure for IgG may lead to a standardized interpretation of covid-19 immunity through test results.
Read More